The Ontario government is investing more than $240 million over three years to help advance research at five leading research institutes across the province, including Clinical Trials Ontario.
“We thank the Government of Ontario for its recognition of the vital role that clinical trials play in this province. At Clinical Trials Ontario, we leverage Ontario’s world-leading health research capacity and work with industry, patient partners, and others to make clinical trials more timely, efficient, and cost-effective. This funding will allow us to continue strengthening the environment to ensure that high-quality clinical trials and new therapies are accessible to Ontarians.”
– Susan Marlin, President and CEO, Clinical Trials Ontario